14-day Premium Trial Subscription Try For FreeTry Free
$1.36
+0.0500 (+3.82%)
At Close: May 03, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $1.14 $1.40 Friday, 3rd May 2024 ACRS stock ended at $1.36. This is 3.82% more than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 6.87% from a day low at $1.31 to a day high of $1.40.
90 days $1.05 $1.51
52 weeks $0.590 $11.12

Historical Aclaris Therapeutics prices

Date Open High Low Close Volume
Jan 19, 2022 $10.02 $10.79 $9.51 $10.14 373 300
Jan 18, 2022 $10.58 $10.75 $10.08 $10.14 521 600
Jan 14, 2022 $10.67 $11.04 $10.42 $10.81 465 900
Jan 13, 2022 $10.99 $11.28 $10.60 $10.87 741 000
Jan 12, 2022 $12.39 $12.39 $10.67 $11.11 1 579 900
Jan 11, 2022 $12.33 $13.01 $11.98 $12.86 423 700
Jan 10, 2022 $12.69 $12.70 $11.75 $12.45 570 400
Jan 07, 2022 $13.03 $13.16 $12.47 $12.70 602 200
Jan 06, 2022 $13.15 $13.56 $12.88 $13.15 203 700
Jan 05, 2022 $13.62 $13.85 $13.14 $13.22 369 158
Jan 04, 2022 $14.51 $14.65 $13.46 $13.63 426 685
Jan 03, 2022 $14.66 $14.86 $14.18 $14.59 315 847
Dec 31, 2021 $14.50 $14.78 $14.36 $14.54 616 475
Dec 30, 2021 $14.51 $15.11 $13.64 $14.33 404 766
Dec 29, 2021 $14.52 $14.83 $14.13 $14.51 167 877
Dec 28, 2021 $15.04 $15.26 $14.60 $14.64 160 096
Dec 27, 2021 $15.32 $15.46 $14.78 $15.30 245 112
Dec 23, 2021 $15.35 $15.56 $14.83 $15.44 181 191
Dec 22, 2021 $14.36 $15.31 $14.26 $15.27 246 730
Dec 21, 2021 $14.53 $14.79 $14.17 $14.51 202 446
Dec 20, 2021 $13.85 $14.37 $13.55 $14.27 451 053
Dec 17, 2021 $13.31 $14.42 $13.00 $13.98 951 309
Dec 16, 2021 $13.85 $14.18 $13.43 $13.54 226 937
Dec 15, 2021 $13.24 $13.73 $12.71 $13.71 411 473
Dec 14, 2021 $13.82 $13.82 $13.12 $13.19 323 399
Click to get the best stock tips daily for free!

About Aclaris Therapeutics

Aclaris Therapeutics Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment engages in the provision of... ACRS Profile

Golden Star

Ticker Date Change Price
CVBF May 01 2.75% $16.75
FTSL May 01 0.282% $46.03
EQC Apr 30 0.694% $18.72
HRB Apr 30 0.635% $47.23
BSCQ Apr 30 0.576% $19.09
BSJP Apr 29 0.306% $22.91
LYG Apr 29 1.56% $2.56
ORA Apr 29 4.68% $64.48
DHT Apr 24 3.10% $11.28
LPLA Apr 19 3.12% $262.59
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT